Search
Search Results
-
Comment prendre en charge un patient porteur de polype hamartomateux ?
Digestive hamartomatous polyps are a rare entity. They may be sporadic (solitary Peutz-Jeghers polyp or solitary juvenile polyp) or reveal a real...
-
Séquelles incapacitantes après chimio- et radiothérapie
An increasing number of patients with cancer become long-term survivors. Currently, chemotherapy and radiotherapy remain the mainstay of cancer...
-
Cancer du sein: l’homme est aussi concerné. Étude de 21 cas
IntroductionBreast cancer, the primary malignancy in women, is a rare disease in men. It represents approximately 1% of breast cancers and less than...
-
Les grands challenges de la prise en charge en phase métastatique aujourd’hui
The management of breast cancer is evolving rapidly. Because of the improvement in treatment of localized breast cancer, the number of patients with...
-
L’association hormonothérapie-thérapie ciblée dans le cancer du sein
Approximately 70–80% of breast cancers expressed estrogen receptors (ER). Endocrine therapy is the main pillar of the medical management of women...
-
Symptômes musculosquelettiques liés aux inhibiteurs de l’aromatase
Aromatase inhibitors (AIs) are widely used as adjuvant endocrine treatment in postmenopausal women with a breast cancer at early stage, with the...
-
Comment identifier les sujets âgés à risque de fracture éligibles à un traitement ?
The elderly at a risk of osteoporotic fractures are mainly detected clinically. Low-energy fractures due to fragility and age are the most important...
-
Les traitements des cancers Précis à l’usage des médecins généralistes
The aim of this article is to help the general practioners in their everyday practice by giving the minimum information necessary to provide care for...